General Information of the Compound
Compound ID |
CP0429046
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[(2S)-3-(1-benzyl-2,5-diiodoimidazol-4-yl)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-1-oxopropan-2-yl]pyrazine-2-carboxamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C23H23I2N7O3
|
||||||||||||||||||
Molecular Weight |
699.291
|
||||||||||||||||||
Canonical SMILES |
NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1nc(I)n(Cc2ccccc2)c1I)NC(=O)c1cnccn1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C23H23I2N7O3/c24-19-15(30-23(25)32(19)13-14-5-2-1-3-6-14)11-16(29-21(34)17-12-27-8-9-28-17)22(35)31-10-4-7-18(31)20(26)33/h1-3,5-6,8-9,12,16,18H,4,7,10-11,13H2,(H2,26,33)(H,29,34)/t16-,18-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
CCRWOBIVNBYGCX-WMZOPIPTSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00626, Thyrotropin-releasing hormone receptor
Protein ID: PT04668, Thyrotropin-releasing hormone receptor